NuGen Competitors

OTC Stocks . USA . 
Stock . NuGen Medical Devices
NGMDF Stock  USD 0.03  0.00  0.00%   
NuGen Medical Devices competes with Comprehensive Healthcare, and Adm Tronics; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Devices industry. Analyzing NuGen Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of NuGen Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out NuGen Medical Correlation with its peers.

NuGen Medical vs Adm Tronics Correlation

Very good diversification

The correlation between NuGen Medical Devices and ADMT is -0.45 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NuGen Medical Devices and ADMT in the same portfolio, assuming nothing else is changed.

Moving together with NuGen OTC Stock

  0.69BSX Boston Scientific CorpPairCorr

Moving against NuGen OTC Stock

  0.92HRMY Harmony BiosciencesPairCorr
  0.85JBHT JB Hunt TransportPairCorr
  0.73BMO Bank of MontrealPairCorr
  0.66MDT Medtronic PLCPairCorr
  0.59STE STERIS plcPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NuGen Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.032.22
Details
Intrinsic
Valuation
LowRealHigh
0.000.022.21
Details
Naive
Forecast
LowNextHigh
0.00050.022.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.030.03
Details

NuGen Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between NuGen Medical and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of NuGen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of NuGen Medical Devices does not affect the price movement of the other competitor.

High positive correlations

ANPCF
+ 0.94
CMHSF
ODYY
+ 0.65
CMHSF
ANPCF
+ 0.65
ODYY
PMEDF
+ 0.58
LIANY
INTI
+ 0.54
ODYY
ADMT
+ 0.41
PMEDF
  

High negative correlations

PMEDF
- 0.75
ANPCF
PMEDF
- 0.75
CMHSF
LIANY
- 0.68
ANPCF
PMEDF
- 0.65
ODYY
LIANY
- 0.6
CMHSF
PNPL
- 0.56
INTI

Risk-Adjusted Indicators

There is a big difference between NuGen OTC Stock performing well and NuGen Medical OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NuGen Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CMHSF  0.31 (0.18) 0.00 (0.70) 0.00 
 0.00 
 0.00 
 0.00 
 10.26 
ODYY  6.72 (0.19) 0.00  0.02  7.97 
(10.15)
 14.29 
(19.11)
 100.78 
NSVGF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ANPCF  1.11 (0.66) 0.00 (0.59) 0.00 
 0.00 
 0.00 
 0.00 
 14.72 
LIANY  5.08  0.97  0.06 (0.55) 5.89 
(11.37)
 12.12 
(11.43)
 60.61 
INTI  6.26  1.24  0.13  0.48  5.64 
(14.37)
 11.63 
(12.00)
 107.08 
PMSNF  8.98  3.53  0.00 (329.47) 0.00 
 0.00 
 0.00 
 0.00 
 300.00 
PMEDF  7.49  1.92  0.12 (0.23) 6.29 
(22.59)
 18.00 
(13.33)
 139.39 
PNPL  2.67 (0.45) 0.00 (0.94) 0.00 
 0.00 
 8.33 
(8.33)
 45.45 
ADMT  6.52  0.83  0.05 (1.65) 7.34 
(15.14)
 22.22 
(18.18)
 40.40 

NuGen Medical Competitive Analysis

The better you understand NuGen Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, NuGen Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across NuGen Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NGMDF CMHSF ODYY NSVGF ANPCF LIANY INTI PMSNF PMEDF PNPL
 0.00 
 0.03 
NuGen
 0.00 
 0.35 
Comprehensive
 6.35 
 0.07 
Odyssey
 0.00 
 0.01 
Nass
 0.00 
 0.02 
ANGLE
 0.00 
 0.09 
LianBio
 45.45 
 0.08 
Inhibitor
 0.00 
 0.04 
Proteome
 2.38 
 0.04 
Predictmedix
 1.23 
 0.08 
Pineapple
Market Volatility
(90 Days Market Risk)
Out of control
Extremely Dangerous
Out of control
Very steady
Out of control
Out of control
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Weakest
Weakest
Soft
Weakest
Weakest
Fair
Fair
Fair
Mild
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Small
Risky
Small
Low
Unknown
Small
Strong
Strong
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.45
0.86
0.12
0.08
6.55
N/A
0.04
0.45
0.83
N/A
Net Asset
8.84 M
4.11 M
569.68 K
1.17 M
47.31 M
N/A
58.78 K
10.04 M
1.24 M
9.5 M
Profit Margin
N/A
-1.29
N/A
N/A
N/A
N/A
N/A
0.0875
N/A
N/A
EBITDA
(5.09 M)
(2.72 M)
(7.61 M)
(4.28 M)
(15.72 M)
N/A
(283.8 K)
625 K
(1.8 M)
(1.09 M)
Operating Margin
-29.06
-1.05
N/A
-42.62
-16.23
N/A
N/A
0.15
-24.76
N/A
Current Valuation
7.67 M
6.59 M
12.08 M
15.82 M
145.22 M
N/A
26.98 M
25.13 M
2.56 M
47.6 M
Price To Book
9.94
12.41
0.77
N/A
3.48
N/A
76.91
N/A
7.28
233.8
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
(60.33 M)
(68 M)
N/A
(1.87 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
2.39 M
2 M
N/A
224 K
Beta
N/A
N/A
-0.47
-0.33
0.43
N/A
-0.46
0.0015
2.08
20.61
Number Of Employees
4
9
4
4
128
N/A
1
27
4
7
Shares Outstanding
96.56 M
124.02 M
75.59 M
312.83 M
260.58 M
N/A
376.86 M
295.18 M
122.05 M
67.15 M
Cash Flow From Operations
(4.1 M)
(3.27 M)
(3.18 M)
(4.84 M)
(14.01 M)
N/A
(220.43 K)
793 K
(1.53 M)
(543)
Total Debt
5.61 M
1.4 M
1.56 M
491.22 K
5.24 M
N/A
331 K
11.68 M
N/A
764.49 K
Return On Equity
-14.72
N/A
-0.35
N/A
-0.56
N/A
N/A
N/A
-2.0
-6.09
Z Score
0.6
4.0
-39.3
5.7
15.0
N/A
N/A
-7.8
-3.3
37.2
Return On Asset
-0.42
-1.29
-6.08
-0.55
-0.3
N/A
-2.11
0.06
-0.8
-0.13
Book Value Per Share
-0.012
-0.037
-0.075
-0.048
0.14
N/A
-0.021
-0.009
0.003
-0.03
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
N/A
19.88 K
N/A
N/A
N/A
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
736.4 K
9 M
N/A
4.24 M
Total Asset
8.84 M
4.11 M
569.68 K
1.17 M
47.31 M
N/A
58.78 K
10.04 M
1.24 M
9.5 M
Debt To Equity
7.4
N/A
0.056
N/A
0.16
N/A
11.81
N/A
0.009
0.11
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.07
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
N/A
N/A
30.3
N/A
N/A
22.89
N/A
N/A
Market Capitalization
5.74 M
8.15 M
9.64 M
12.79 M
135.5 M
N/A
22.99 M
14.76 M
10.31 M
47.56 M
Price To Earning
N/A
N/A
N/A
N/A
N/A
N/A
-4.67
50.0
N/A
N/A
Price To Sales
13.04
1.3
N/A
530.48
144.24
N/A
N/A
2.31
30.93
N/A
Net Income
(7.11 M)
(4.93 M)
(8.44 M)
(4.41 M)
(15.01 M)
N/A
(298.63 K)
72 K
(1.88 M)
(1.15 M)
Earnings Per Share
-0.076
0.18
-0.1
-0.007
-0.082
N/A
-0.001
N/A
-0.013
N/A
Shares Owned By Insiders
19.15
35.13
27.53
67.02
10.75
N/A
79.33
21.49
31.03
65.36
Revenue
137.65 K
4.5 M
N/A
56.27 K
1.01 M
N/A
N/A
5.13 M
134.82 K
N/A
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
1.65 M
(7 M)
N/A
(4.02 M)
Cash And Equivalents
87.48 K
1.27 M
266.3 K
15.25 K
20.5 M
N/A
24.95 K
3.2 M
283.44 K
21
Cash Per Share
N/A
0.02
N/A
N/A
0.09
N/A
N/A
0.01
N/A
N/A
Gross Profit
47.3 K
1.37 M
N/A
8.02 K
54 K
N/A
N/A
2.96 M
84.82 K
15 K
Day Typical Price
0.025
0.35
0.065
0.01
0.0168
0.093
0.08
0.04
0.041
0.08
Accumulation Distribution
N/A
N/A
0.0896
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
0.006
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
0.0
0.6667
0.0
0.0
0.0
9.2 T
0.0
0
0
Period Momentum Indicator
N/A
N/A
0.004
N/A
N/A
N/A
0.025
N/A
(0)
(0)
Rate Of Daily Change
1.0
1.0
1.06
1.0
1.0
1.0
1.45
1.0
0.98
0.99
Day Median Price
0.025
0.35
0.064
0.01
0.0168
0.093
0.08
0.04
0.041
0.08
Price Action Indicator
N/A
N/A
0.005
N/A
N/A
N/A
0.0125
N/A
(0.0005)
(0.0005)
Relative Strength Index
N/A
N/A
57.29
N/A
N/A
51.72
61.22
61.02
47.79
25.51
Coefficient Of Variation
(606.16)
(806.23)
17906.64
N/A
(461.39)
1046.41
933.04
1073.48
1151.83
(1,513)
Mean Deviation
0.8725
0.3107
6.72
N/A
1.11
5.08
6.26
8.98
7.49
2.67
Jensen Alpha
(0.35)
(0.18)
(0.19)
N/A
(0.66)
0.9667
1.24
3.53
1.92
(0.45)
Total Risk Alpha
(0.60)
(0.29)
(1.15)
N/A
(0.84)
0.0101
0.1776
(0.02)
(0.12)
(1.00)
Sortino Ratio
N/A
N/A
(0.0005)
N/A
N/A
0.0648
0.1302
N/A
0.1201
N/A
Downside Variance
N/A
N/A
114.03
N/A
N/A
148.92
111.76
N/A
137.06
N/A
Standard Deviation
2.27
1.27
13.04
N/A
2.68
9.09
13.58
37.95
17.1
6.24
Kurtosis
20.91
65.0
22.76
N/A
20.31
6.85
23.32
59.88
35.29
8.0
Potential Upside
N/A
N/A
14.29
N/A
N/A
12.12
11.63
N/A
18.0
8.33
Treynor Ratio
0.6919
(0.70)
0.0167
N/A
(0.59)
(0.55)
0.4762
(329.47)
(0.23)
(0.94)
Maximum Drawdown
18.63
10.26
100.78
N/A
14.72
60.61
107.08
300.0
139.39
45.45
Variance
5.15
1.62
170.11
N/A
7.17
82.71
184.29
1440.3
292.54
38.88
Market Risk Adjusted Performance
0.7019
(0.69)
0.0267
N/A
(0.58)
(0.54)
0.4862
(329.46)
(0.22)
(0.93)
Risk Adjusted Performance
(0.11)
(0.09)
0.0135
N/A
(0.15)
0.0792
0.0879
0.078
0.0731
(0.04)
Skewness
(4.11)
(8.06)
3.71
N/A
(4.59)
1.25
4.12
7.46
5.23
(0.52)
Semi Deviation
N/A
N/A
7.97
N/A
N/A
5.89
5.64
N/A
6.29
N/A
Information Ratio
(0.20)
(0.19)
(0.0004)
N/A
(0.25)
0.0869
0.1014
0.0911
0.0822
(0.08)
Value At Risk
N/A
N/A
(19.11)
N/A
N/A
(11.43)
(12.00)
N/A
(13.33)
(8.33)
Expected Short fall
N/A
N/A
(10.15)
N/A
N/A
(11.37)
(14.37)
N/A
(22.59)
N/A
Downside Deviation
N/A
N/A
10.68
N/A
N/A
12.2
10.57
N/A
11.71
N/A
Semi Variance
N/A
N/A
63.57
N/A
N/A
34.72
31.84
N/A
39.6
N/A

NuGen Medical Competition Performance Charts

Five steps to successful analysis of NuGen Medical Competition

NuGen Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by NuGen Medical Devices in relation to its competition. NuGen Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of NuGen Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact NuGen Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to NuGen Medical Devices, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your NuGen Medical position

In addition to having NuGen Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recycling Thematic Idea Now

Recycling
Recycling Theme
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in NuGen OTC Stock

NuGen Medical financial ratios help investors to determine whether NuGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGen with respect to the benefits of owning NuGen Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY